Showing results (11-20 of 175) with videos related to
Sort By:
Pageof 18
Drug News & Perspectives|December 24, 2004
Cholecystokinin as a target for neuropsychiatric drugsM BourinPolish Journal of Pharmacology|March 1, 1997
Animal models of anxiety: are they suitable for predicting drug action in humans?M BourinFundamental & Clinical Pharmacology|January 1, 1990
Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests?M BourinL'Encephale|July 1, 1988
[A scale for evaluating withdrawal symptoms induced by anxiolytic agents]M BourinL'Encephale|September 1, 1992
[Efficacy of tianeptine in the treatment of psychasthenia. A study versus placebo]H Grivois, P Deniker, H GanryCurrent Medical Research and Opinion|March 16, 2011
Epidemiological data, efficacy and safety of a paracetamol-tramadol fixed combination in the treatment of moderate-to-severe pain. SALZA: a post-marketing study in general practiceO Mejjad, A Serrie, H GanryDrug News & Perspectives|December 24, 2004
Pharmacology of new antipsychotic drugs: are they stabilizers of schizophrenic psychosis?P Jolliet, M BourinPharmacology, Biochemistry, and Behavior|February 1, 1997
Anticonflict effect of alpidem as compared with the benzodiazepine alprazolam in ratsM Hascoët, M BourinCurrent Opinion in Investigational Drugs (London, England : 2000)|January 31, 2002
Drug mechanisms in anxietyM Bourin, M HascoëtCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 1, 1991
[Clinical and neurobiological aspects of long-term administration of psychotropic drugs]M Bourin, J BradwejnPageof 18